SMCP (SMCP) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
3 Aug, 2026Executive summary
H1 2024 sales reached €585m, down 3.6% organically and 4.0% year-over-year, with resilience in Europe and America offset by a 20% organic decline in APAC, mainly due to China; Sandro and Maje performed well outside China.
Adjusted EBIT margin fell to 3.2% of sales, impacted by restructuring, inflation, and non-cash impairments; net income was -€27.7m to -€28m, break-even before non-recurring items.
Network optimization led to 29 store closures in H1, mainly in China and Asia, with further closures planned; Claudie Pierlot repositioning and discontinuation in Asia ongoing.
Digital sales remained above 20% of total; new digital platforms launched and expansion into India and Southeast Asia planned.
Sustainability initiatives led to a 15% CO2 emissions reduction from 2022 to 2023 and new Diversity & Inclusion policies.
Financial highlights
Gross margin improved to 74.3% of sales, up over one point year-over-year, driven by a strict full-price strategy and reduced discounting.
Adjusted EBITDA was €98.5m (17% margin), down from 19% in H1 2023; adjusted EBIT was €18.8m–€19m (3.2% margin), down from €36m (6%).
Free cash flow was -€8.8m to -€9m, stable year-over-year, supported by inventory and CapEx control.
Net debt at €293m, down €13m year-over-year, with a net debt/EBITDA ratio of 3.05x; covenant waiver granted up to 3.4x.
Inventory reduced by 7% year-over-year, supporting improved working capital.
Outlook and guidance
H2 expected to benefit from more favorable comps starting August and positive reception of fall-winter collections; cautious outlook due to ongoing macroeconomic and political uncertainty.
Ongoing execution of action plans focused on growth, cost management, and further network optimization, especially in China.
Mid-term plan targets €25m positive EBIT impact by 2026, with digital, retail, and wholesale initiatives.
Latest events from SMCP
- Adjusted EBIT rose 25% and net income 52%, with leverage at 1.1x and guidance reaffirmed.SMCP
H1 20263 Aug 2026 - Q1 2025 sales up 3.4% to €297m, led by France and EMEA, with APAC declining.SMCP
Q1 2025 TU8 Jul 2026 - Q1 2026 sales held steady at €287M, with robust growth in America and EMEA but a sharp drop in France.SMCP
Q1 2026 TU28 Apr 2026 - Resilient 2024 performance, global expansion, and strong RSE progress marked the AGM.SMCP
AGM 202523 Apr 2026 - Record profitability, free cash flow, and margin gains in 2025, with 2026 guidance reaffirmed.SMCP
H2 202526 Feb 2026 - Sales fell 2.7% organically as China lagged, but Europe and America remained resilient.SMCP
Q3 2024 TU18 Jan 2026 - Resilient sales and strong cash flow set up margin recovery and €50m FCF by 2026.SMCP
H2 20247 Jan 2026 - 9M sales up 2.8% organically to €896m, led by EMEA and America, with APAC declining.SMCP
Q3 2025 TU13 Dec 2025 - Adjusted EBIT margin more than doubled and net income turned positive on strong H1 2025 results.SMCP
H1 202516 Nov 2025